Works matching IS 02780232 AND DT 2021 AND VI 39 AND IP 4

Results: 21

Outcomes and prognostic factors of adults with refractory or relapsed T‐cell acute lymphoblastic leukemia included in measurable residual disease‐oriented trials.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 529, doi. 10.1002/hon.2910
By:
- Ribera, Josep‐Maria;
- Morgades, Mireia;
- Genescà, Eulàlia;
- Chapchap, Eduardo‐Cerello;
- Montesinos, Pau;
- Acuña‐Cruz, Evelyn;
- Gil, Cristina;
- García‐Cadenas, Irene;
- Barba, Pere;
- González‐Campos, José;
- Queipo de Llano, María‐Paz;
- Torrent, Anna;
- Ribera, Jordi;
- Granada, Isabel;
- Bernal, Teresa;
- Díaz‐Beyá, Marina;
- Amigo, María‐Luz;
- Coll, Rosa;
- Tormo, Mar;
- Vall‐llovera, Ferran
Publication type:
Article
Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 521, doi. 10.1002/hon.2906
By:
- Højholt, Karen Louise;
- Gregersen, Henrik;
- Szabo, Agoston Gyula;
- Klausen, Tobias Wirenfeldt;
- Levring, Mette Bøegh;
- Preiss, Birgitte;
- Helleberg, Carsten;
- Breinholt, Marie Fredslund;
- Hermansen, Emil;
- Rahbek Gjerdrum, Lise Mette;
- Bønløkke, Søren Thorgaard;
- Nielsen, Katrine;
- Kjeldsen, Eigil;
- Iversen, Katrine Fladeland;
- Teodorescu, Elena Manuela;
- Kurt, Eva;
- Strandholdt, Casper;
- Andersen, Mette Klarskov;
- Vangsted, Annette Juul
Publication type:
Article
CD38 expression is an important prognostic marker in diffuse large B‐cell lymphoma.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 483, doi. 10.1002/hon.2904
By:
- Wada, Fumiya;
- Shimomura, Yoshimitsu;
- Yabushita, Tomohiro;
- Yamashita, Daisuke;
- Ohno, Aya;
- Imoto, Hiroharu;
- Maruoka, Hayato;
- Hara, Shigeo;
- Ishikawa, Takayuki
Publication type:
Article
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 589, doi. 10.1002/hon.2903
By:
- Trotti, Chiara;
- Sant'Antonio, Emanuela;
- Vanni, Daniele;
- Casetti, Ilaria Carola;
- Borsani, Oscar;
- Pietra, Daniela;
- Ferretti, Virginia Valeria;
- Astori, Cesare;
- Arcaini, Luca;
- Rumi, Elisa
Publication type:
Article
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 580, doi. 10.1002/hon.2886
By:
- Papayannidis, Cristina;
- Sartor, Chiara;
- Dominietto, Alida;
- Zappone, Elisabetta;
- Arpinati, Mario;
- Marconi, Giovanni;
- Cristiano, Gianluca;
- Nanni, Jacopo;
- Parisi, Sarah;
- Barbato, Francesco;
- Paolini, Stefania;
- Soverini, Simona;
- Terragna, Carolina;
- Robustelli, Valentina;
- Testoni, Nicoletta;
- Chirumbolo, Gabriella;
- Curti, Antonio;
- Cavo, Michele;
- Bonifazi, Francesca
Publication type:
Article
RBCK1‐TRIB3 decelerated the progression of acute promyelocytic leukemia.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 567, doi. 10.1002/hon.2901
By:
- Zhang, Xiang;
- Yu, Wenjuan
Publication type:
Article
Immunoglobulin replacement therapy discontinuation in patients with antibody deficiency secondary to hematological malignancy.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 584, doi. 10.1002/hon.2900
By:
- Patel, Vishesh;
- Cameron, Donald William;
- Cowan, Juthaporn
Publication type:
Article
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID‐19 pandemic and at the start of the vaccination program. A Campus CLL report.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 570, doi. 10.1002/hon.2899
By:
- Cuneo, Antonio;
- Rigolin, Gian Matteo;
- Coscia, Marta;
- Quaresmini, Giulia;
- Scarfò, Lydia;
- Mauro, Francesca Romana;
- Motta, Marina;
- Quaglia, Francesca Maria;
- Trentin, Livio;
- Ferrario, Andrea;
- Laurenti, Luca;
- Reda, Gianluigi;
- Ferrari, Angela;
- Pietrasanta, Daniela;
- Sportoletti, Paolo;
- Re, Francesca;
- De Paoli, Lorenzo;
- Foglietta, Myriam;
- Giordano, Annamaria;
- Marchetti, Monia
Publication type:
Article
Perirenal and subcutaneous fat differently affect outcomes in newly diagnosed classical Hodgkin lymphoma patients.
Published in:
2021
By:
- Lucijanic, Marko;
- Huzjan Korunic, Renata;
- Ivic, Marija;
- Fazlic Dzankic, Amina;
- Kusec, Rajko;
- Pejsa, Vlatko
Publication type:
Letter
Impact of initial chemotherapy regimen on outcomes for patients with double‐expressor lymphoma: A multi‐center analysis.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 473, doi. 10.1002/hon.2902
By:
- D'Angelo, Christopher R.;
- Hanel, Walter;
- Chen, Yi;
- Yu, Menggang;
- Yang, David;
- Guo, Ling;
- Karmali, Reem;
- Burkart, Madelyn;
- Ciccosanti, Colleen;
- David, Kevin;
- Risch, Zachary;
- Murga‐Zamalloa, Carlos;
- Devata, Sumana;
- Wilcox, Ryan;
- Savani, Malvi;
- Courville, Elizabeth L.;
- Bachanova, Veronika;
- Rabinovich, Emma;
- Peace, David;
- Osman, Fauzia
Publication type:
Article
Subsequent attempt tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia; a single institute experience.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 549, doi. 10.1002/hon.2896
By:
- Ureshino, Hiroshi;
- Kamachi, Kazuharu;
- Nishioka, Atsujiro;
- Okamoto, Sho;
- Katsuya, Hiroo;
- Yoshimura, Mariko;
- Kubota, Yasushi;
- Ando, Toshihiko;
- Kimura, Shinya
Publication type:
Article
Downregulation of circ_0012152 inhibits proliferation and induces apoptosis in acute myeloid leukemia cells through the miR‐625‐5p/SOX12 axis.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 539, doi. 10.1002/hon.2895
By:
- Shang, Zhen;
- Ming, Xi;
- Wu, Jiaying;
- Xiao, Yi
Publication type:
Article
Lenalidomide abrogates the survival effect of bone marrow stromal cells in chronic lymphocytic leukemia.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 513, doi. 10.1002/hon.2888
By:
- Kriston, Csilla;
- Hernádfői, Márk;
- Plander, Márk;
- Márk, Ágnes;
- Takács, Ferenc;
- Czeti, Ágnes;
- Szalóki, Gábor;
- Szabó, Orsolya;
- Matolcsy, András;
- Barna, Gábor
Publication type:
Article
Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low‐, intermediate‐1‐, intermediate‐2‐, and high‐risk myelofibrosis in JUMP, a Phase 3b, expanded‐access study
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 558, doi. 10.1002/hon.2898
By:
- Passamonti, Francesco;
- Gupta, Vikas;
- Martino, Bruno;
- Foltz, Lynda;
- Zaritskey, Andrey;
- Al‐Ali, Haifa Kathrin;
- Tavares, Renato;
- Maffioli, Margherita;
- Raanani, Pia;
- Giraldo, Pilar;
- Griesshammer, Martin;
- Guglielmelli, Paola;
- Bouard, Catherine;
- Paley, Carole;
- Tiwari, Ranjan;
- Vannucchi, Alessandro M.
Publication type:
Article
Brentuximab vedotin consolidation therapy after autologous stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 498, doi. 10.1002/hon.2897
By:
- Akay, Olga Meltem;
- Ozbalak, Murat;
- Pehlivan, Mustafa;
- Yildiz, Birol;
- Uzay, Ant;
- Yigenoglu, Tugce Nur;
- Elverdi, Tugrul;
- Kaynar, Leylagul;
- Ayyildiz, Orhan;
- Yonal Hindilerden, Ipek;
- Goksoy, Hasan Sami;
- Izmir Guner, Sebnem;
- Gunes, Ahmet Kursad;
- Sonmez, Mehmet;
- Kurt Yuksel, Meltem;
- Civriz Bozdag, Sinem;
- Ozkurt, Zubeyde Nur;
- Toptas, Tayfur;
- Dogu, Mehmet Hilmi;
- Salim, Ozan
Publication type:
Article
Safety and efficacy of autologous whole cell vaccines in hematologic malignancies: A systematic review and meta‐analysis.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 448, doi. 10.1002/hon.2875
By:
- Bastin, Donald J.;
- Khan, Sarwat T.;
- Montroy, Joshua;
- Kennedy, Michael A.;
- Forbes, Nicole;
- Martel, Andre B;
- Baker, Laura;
- Gresham, Louise;
- Boucher, Dominique M.;
- Wong, Boaz;
- Shorr, Risa;
- Diallo, Jean‐Simon;
- Fergusson, Dean A.;
- Lalu, Manoj M.;
- Auer, Rebecca C.;
- Kekre, Natasha
Publication type:
Article
Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B‐cell lymphomas.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 465, doi. 10.1002/hon.2871
By:
- Takezaki, Toshiaki;
- Nakazaki, Kumi;
- Toyama, Kazuhiro;
- Matsuda, Kensuke;
- Kogure, Yasunori;
- Chiba, Akira;
- Nakamura, Fumihiko;
- Honda, Akira;
- Kurokawa, Mineo
Publication type:
Article
Reduced radiotherapy clinical benefit for primary Waldeyer's ring diffuse large B‐cell lymphoma in the rituximab era.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 490, doi. 10.1002/hon.2869
By:
- Guan, Qingpei;
- Hong, Yuheng;
- Hu, Ge;
- Zhou, Qiqi;
- Li, Lanfang;
- Qian, Zhengzi;
- Zhou, Shiyong;
- Ren, Xiubao;
- Qiu, Lihua;
- Wang, Xianhuo;
- Zhang, Huilai
Publication type:
Article
Hepatitis C virus‐associated indolent B‐cell lymphomas: A review on the role of the new direct antiviral agents therapy.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 439, doi. 10.1002/hon.2862
By:
- Mazzaro, Cesare;
- Dal Maso, Luigino;
- Visentini, Marcella;
- Ermacora, Anna;
- Andreone, Pietro;
- Gattei, Valter;
- Pozzato, Gabriele
Publication type:
Article
Long‐term follow‐up of patients with nodular lymphocyte predominant Hodgkin lymphoma: A report from the Spanish Lymphoma Oncology Group.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 506, doi. 10.1002/hon.2835
By:
- Núñez‐García, Beatriz;
- Rodríguez‐Pertierra, Marta;
- Sequero, Silvia;
- Carvajal, Laura G.;
- Ruano‐Ravina, Alberto;
- Aguiar, David;
- Gumá, Josep;
- Blanco, Cristina Q.;
- García Arroyo, Francisco R.;
- Garitaonaindia, Yago;
- Provencio, Zaida;
- Calvo, Virginia;
- González‐San Segundo, Carmen;
- Provencio, Mariano
Publication type:
Article
Issue Information.
Published in:
Hematological Oncology, 2021, v. 39, n. 4, p. 437, doi. 10.1002/hon.2748
Publication type:
Article